Renal function in patients receiving streptozocin for locally advanced or metastatic digestive neuroendocrine tumours: results of the Streptotox-FFCD 0906 study-Reference-Cited by-同舟云学术

Renal function in patients receiving streptozocin for locally advanced or metastatic digestive neuroendocrine tumours: results of the Streptotox-FFCD 0906 study

Published:2021-09 Issue:5 Volume:45 Page:101572
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Legoux Jean-Louis,Lombard-Bohas Catherine,Brixi Hedia,Le Malicot Karine,Lecomte Thierry,Dahan Laetitia,Ruszniewski Philippe,Mahamat-Abakar Abakar,Etienne Pierre-Luc,Caroli-Bosc François-Xavier,Dominguez Sophie,Paule Bernard,Terrebonne Eric,Michel Pierre,Lepage Côme,Choukroun Gabriel

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours;Lepage;Eur J Endocrinol,2013

2. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017

3. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site;Pavel;Neuroendocrinology,2016

4. Digestive neuroendocrine neoplasms (NEN): french intergroup clinical practice guidelines for diagnosis,treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR);de Mestier;Dig Liver Dis,2020

5. The North America Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors;Strosberg;Pancreas,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice;Japanese Journal of Clinical Oncology;2024-02-29

2. Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors;Neuroendocrinology;2022

3. Streptozocin;Reactions Weekly;2021-05